Me-Tet-PEG9-COOH is a methyl-tetrazine functionalized long PEG9 linker with carboxyl group, enabling rapid and stable bioorthogonal conjugation for payload attachment in antibody-drug conjugates. Keywords: ADC linker, methyl-tetrazine linker, PEG spacer, long PEG linker, payload conjugation.
Structure of 2143964-70-7
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Me-Tet-PEG9-COOH, a specialized polyethylene glycol derivative featuring a terminal carboxylic acid group, finds extensive use in bioconjugation and biomedical applications. Here are four key applications of Me-Tet-PEG9-COOH
Drug Delivery Systems: Leveraging the unique properties of Me-Tet-PEG9-COOH, researchers enhance the pharmacokinetics of drug molecules by boosting their solubility and stability. PEGylation of drugs contributes to extending their circulatory lifespan and diminishing immunogenic responses, thereby elevating their therapeutic efficacy. This attribute renders Me-Tet-PEG9-COOH indispensable for formulating enduring and precisely targeted therapeutic agents.
Bioconjugation: Embraced in bioconjugation chemistry, Me-Tet-PEG9-COOH serves as a pivotal agent for anchoring biomolecules like proteins and peptides onto diverse surfaces. The presence of a terminal carboxylic acid group facilitates covalent bonding with amine groups, fostering the creation of robust bioconjugates. This application is particularly instrumental in crafting cutting-edge diagnostic tools and biofunctionalized materials, pushing the boundaries of biotechnology forward.
Tissue Engineering: Within the realm of tissue engineering, Me-Tet-PEG9-COOH plays a crucial role in tailoring biomaterials to elevate their biocompatibility and functional attributes. By conjugating biomolecules onto scaffolds, it bolsters cell adhesion and proliferation, thereby nurturing tissue regeneration. This application stands as a linchpin in the development of engineered tissues and organs.
Surface Modification: Employing this compound for surface modification purposes, researchers alter the surfaces of nanoparticles and other materials to confer desired traits like hydrophilicity and resistance to protein adsorption. Such modifications are imperative in crafting materials for medical devices and implants, ensuring minimized undesired interactions and enhanced performance for biomedical applications.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-01853 | Me-Tet-PEG4-COOH | 2141976-30-7 | |
BADC-01859 | Me-Tet-PEG5-COOH | 2143964-72-9 | |
BADC-01802 | Me-Tet-PEG2-COOH | 2741759-99-7 |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.